[Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity]. 1994

E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
Katedra i Zakład Mikrobiologii AM we Wrocławiu.

The study involved 412 strains of Gram-positive cocci isolated from throat, sputum, urine and stool of patients prepared for bone marrow transplantation at Department of Hematology. Determination of drug susceptibility was performed by disc diffusion method applying discs with roxithromycin, erythromycin, lincomycin, clindamycin and augmentin. Among strains of S. aureus, S. epidermidis and Micrococcus susceptible strains comprised respectively 48, 48 and 45%; among group A, B, C and G streptococci respectively 92 and 52%. Among 108 strains of group D Streptococci only 24% were susceptible to roxithromycin. Comparison of susceptibility of tested strains to roxithromycin and other antibiotics revealed similar susceptibility of staphylococci and streptococci to roxithromycin and erythromycin, while among staphylococci higher percentage of strains and among streptococci lower percentage was susceptible to lincomycin than to roxithromycin.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006095 Gram-Positive Cocci Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method. Gram Positive Cocci
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015575 Roxithromycin Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections. Biaxsig,Claramid,Infectoroxit,MTW-Roxithromycin,Macrosil,RU 28965,RU 965,RU-28965,RU-965,Rotesan,Rotramin,Roxi 1A Pharma,Roxi Basics,Roxi TAD,Roxi-Puren,Roxi-Q,Roxi-Wolff,Roxi-paed 1A Pharma,Roxi-saar,Roxibeta,Roxigamma,Roxigrün,Roxihexal,Roxithro-Lich,Rulid,Rulide,roxi von ct,roxidura,RU28965,RU965
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
September 1998, Rinsho byori. The Japanese journal of clinical pathology,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
February 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
June 1994, Microbiological research,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
July 1994, The Indian journal of medical research,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
January 1992, Diagnostic microbiology and infectious disease,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
January 1987, Antimicrobial agents and chemotherapy,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
November 1992, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
February 1993, International journal of antimicrobial agents,
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
January 2009, Bacteriologia, virusologia, parazitologia, epidemiologia (Bucharest, Romania : 1990),
E Mróz, and M Podolak-Dawidziak, and K Grzybek-Hryncewicz, and E Dworniczek
September 1950, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!